Madrigal Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC MDGL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

23,846

Value ($000)

13,886

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	13,886	0.0%	23,846	12/31/2025
2025 Q3	11/14/2025	10,768	0.0%	23,476	9/30/2025
2025 Q2	8/14/2025	12,048	0.0%	39,809	6/30/2025
2025 Q1	5/19/2025	8,732	0.0%	26,363	3/31/2025
2024 Q4	2/14/2025	8,497	0.0%	27,538	12/31/2024
2024 Q3	11/14/2024	4,744	0.0%	22,356	9/30/2024
2024 Q2	8/14/2024	6,894	0.0%	24,609	6/30/2024
2024 Q1	5/15/2024	3,801	0.0%	14,235	3/31/2024
2023 Q4	2/14/2024	3,294	0.0%	14,235	12/31/2023
2023 Q3	11/13/2023	2,311	0.0%	15,826	9/30/2023
2023 Q2	8/11/2023	3,748	0.0%	15,472	6/30/2023
2023 Q1	5/15/2023	3,748	0.0%	15,472	3/31/2023
2022 Q3	11/14/2022	1,081	0.0%	16,634	9/30/2022
2022 Q2	8/12/2022	1,191	0.0%	16,634	6/30/2022
2022 Q1	5/16/2022	1,220	0.0%	12,430	3/31/2022
2021 Q4	2/14/2022	1,053	0.0%	12,430	12/31/2021
2021 Q3	11/15/2021	992	0.0%	12,430	9/30/2021
2021 Q2	8/16/2021	1,211	0.0%	12,430	6/30/2021
2021 Q1	5/14/2021	1,383	0.0%	11,823	3/31/2021
2020 Q4	3/1/2021	1,078	0.0%	9,701	12/31/2020
2020 Q3	11/13/2020	1,114	0.0%	9,384	9/30/2020
2020 Q2	8/14/2020	976	0.0%	8,615	6/30/2020
2020 Q1	5/15/2020	240	0.0%	3,592	3/31/2020
2019 Q4	2/14/2020	641	0.0%	7,036	12/31/2019